Company: MBIO
Filing Date: 2025-02-07
Form Type: 424B4
Source: 0001410578-25-000085
Chunk: 62

Company: MUSTANG BIO, INC.
Filing Date: 2025-02-07
Form: 424B4
Chunk 62
---
 for infringement of third-party patents or other proprietary rights. We may have limited, if any, control or involvement over the defense of these claims, and our licensors could be subject to injunctions and temporary or permanent exclusionary orders in the U.S. or other countries. Our licensors are not obligated to defend or assist in our defense against third-party claims of infringement. We have limited, if any, control over the amount or timing of resources, if any, that our licensors devote on our behalf or the priority they place on defense of such third-party claims of infringement. Because of the uncertainty inherent in any patent or other litigation involving proprietary rights, we or our licensors may not be successful in defending claims of intellectual property infringement alleged by third parties, which could have a material adverse effect on our results of operations. Regardless of the outcome of any litigation, defending the litigation may be expensive, time-consuming and distracting to management. Protecting our proprietary rights is difficult and costly, and we may be unable to ensure their protection. The degree of future protection for our proprietary rights is uncertain, because legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep our competitive advantage, in addition to being costly and time consuming to undertake. For example:

| ● | our licensors might not have been the first to make the inventions covered by each of our pending patent applications and issued patents; |

| ● | our licensors might not have been the first to file patent applications for these inventions; |

| ● | others may independently develop similar or alternative technologies or duplicate our product candidates or any future product candidate technologies; |

| ● | it is possible that none of the pending patent applications licensed to us will result in issued patents; |

| ● | the scope of our issued patents may not extend to competitive products developed or produced by others; |

| ● | the issued patents covering our product candidates or any future product candidate may not provide a basis for market exclusivity for active products, may not provide us with any competitive advantages, or may be challenged by third parties; |

| ● | we may not develop additional proprietary technologies that are patentable; or |

| ● | intellectual property rights of others may have an adverse effect on our business. |

We may become involved in lawsuits to protect or enforce our patents or other intellectual property, which could be expensive, time consuming and unsuccessful, and an unfavorable outcome in any litigation would harm our business. Competitors may infringe our issued patents or other intellectual property. To counter infringement or unauthorized use,